Results 151 to 160 of about 334,030 (336)

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. [PDF]

World J Gastrointest Oncol, 2023
Lai HC, Lin HJ, Jeng LB, Huang ST.
europepmc   +1 more source

Use of Complementary Therapies by Patients with IBD May Indicate Psychosocial Distress [PDF]

, 2002
Louise Langmead, Meenali Chitnis, David S. Rampton   +2 more
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Editorial: Alternative and complementary therapies to promote mental health and wellbeing for older adults. [PDF]

Front Psychol, 2023
Qi M, Jones C.
europepmc   +1 more source

Use of Complementary/Integrative Nutritional Therapies during Cancer Treatment: Implications in Clinical Practice [PDF]

, 2002
Nagi B. Kumar, Keandra Hopkins, Kathy Allen, Diane Riccardi, Karen Besterman‐Dahan, Susan Moyers   +5 more
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Complementary and Alternative Medicine Use and Its Impact on the Delayed Presentation and Advanced Stage of Breast Cancer in Newly Diagnosed Indian Women

Indian Journal of Medical and Paediatric Oncology
Introduction Complementary and alternate medicine (CAM) use is highly prevalent among Indian cancer patients. However, such studies from the perspective of Indian patients with breast cancer (BC) are lacking.
Amol Pawar, Ashok Diwan, Vijay Mahobia
doaj   +1 more source

Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. [PDF]

Adv Nutr, 2022
Alesi S, Ee C, Moran LJ, Rao V, Mousa A.
europepmc   +1 more source

ABC of complementary medicine: The manipulative therapies: osteopathy and chiropractic

, 1999
Andrew J. Vickers, C. Zollman
openalex   +2 more sources